Citigroup Cuts Hims & Hers Health (NYSE:HIMS) Price Target to $25.00
Hims & Hers Health (NYSE:HIMS – Free Report) had its price objective lowered by Citigroup from $27.00 to $25.00 in a research report released on Friday,Benzinga reports. The brokerage currently has a sell rating on the stock. Several other equities analysts have also recently commented on the stock. BTIG Research began coverage on shares of […]
Hims & Hers Health (NYSE:HIMS – Free Report) had its price objective lowered by Citigroup from $27.00 to $25.00 in a research report released on Friday,Benzinga reports. The brokerage currently has a sell rating on the stock. Several other equities analysts have also recently commented on the stock. BTIG Research began coverage on shares of […]
